Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Kinetics of Transmural Healing in Patients With Crohns Disease Treated With Risankizumab (SKYRIZI®)

NCT07308067 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.

NCT NCT07308067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07308067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Kinetics of Transmural Healing in Patients With Crohns Disease Treated With Risankizumab (SKYRIZI®)
Lead sponsor
University Hospital, Clermont-Ferrand
Phase
Observational
Overall status
Active, not recruiting
Start date
April 15, 2025
Completion date
July 31, 2026
Enrollment
109 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease (cd)